医药导报2024，Vol.43Issue(7)：1038-1045,8.DOI:10.3870/j.issn.1004-0781.2024.07.002
《精神疾病治疗药物的术前管理:围手术期评估和质量改善协会共识声明》解读
Interpretation of Preoperative Management of Medications for Psychiatric Diseases:Society for Perioperative Assessment and Quality Improvement Consensus Statement
摘要
Abstract
The lack of preoperative guidelines for the management of drugs for psychiatric disorders will affect the quality of surgical management of psychiatric patients and increase the probability of perioperative complications.To standardize the preoperative management of medications for the treatment of mental disorders,the Perioperative Assessment and Quality Improvement Society issued《Preoperative Management of Medications for Psychiatric Diseases:Society for Perioperative Assessment and Quality Improvement Consensus Statement》in February 2022 to provide clinicians with recommendations for the preoperative management of psychotropic medications.This article interpreted the consensus,summarized the perioperative interactions,special precautions,and auxiliary examination precautions,and provided corresponding preoperative suggestions on antidepressants,mood stabilizers,anxiety,antipsychotics,and attention deficit hyperactivity disorder drugs,to provide a reference for the standardized management of perioperative drugs.关键词
精神疾病治疗药物/围手术期药物管理/指南解读Key words
Medication for mental disorders/Perioperative drug management/Interpretation of guidelines分类
医药卫生引用本文复制引用
谢菡,马旭东,葛卫红,张海霞,盛梦迪..《精神疾病治疗药物的术前管理:围手术期评估和质量改善协会共识声明》解读[J].医药导报,2024,43(7):1038-1045,8.基金项目
南京大学现代医院管理与发展研究所课题(NDYG2021044) （NDYG2021044）
奥赛康医院药学基金科研课题(A202108). （A202108）
